Platinum
KURA Oncology
- Kelly Wilson
- April 30, 2025
- No Comments
Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. Our small-molecule drug candidates target signaling pathways and other drivers of cancer where there is a strong scientific and clinical rationale to improve outcomes by identifying those patients most likely to benefit from treatment. Kura’s…
Sumitomo Pharma America, Inc.
- Kelly Wilson
- April 11, 2024
- No Comments
Sumitomo Pharma America (SMPA) is deeply committed to accelerating scientific and therapeutic breakthroughs to support patient-first outcomes in areas of critical need, including psychiatry & neurology, oncology, urology, women’s health, rare disease, and cell & gene therapies. SMPA aims to address a wide range of indications where treatment options remain limited or nonexistent. By doing…
Sobi, Inc.
- Amanda Bridges
- August 11, 2022
- No Comments
At Sobi North America, we are committed to delivering treatment options for patients with Immune thrombocytopenia (ITP), a rare autoimmune disease affecting platelet production and characterized by fatigue, bruising and bleeding. Today, there is increased awareness of the available treatment options, and better life may be possible for people living with ITP.Our portfolio also addresses…
ADC Therapeutics
- Amanda Bridges
- July 13, 2021
- No Comments
ADC Therapeutics. Confronting cancer with the full potential of our science. ADC Therapeutics is a commercial-stage biotechnology company improving the lives of cancer patients with its next-generation, targeted antibody drug conjugates (ADCs. ADC Therapeutics is advancing its proprietary PBD-based ADC technology to transform the treatment paradigm for patients with hematologic malignancies and solid tumors. Visit…
Deciphera Pharmaceuticals
- Katrina Williams
- May 20, 2020
- No Comments
Deciphera is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. In addition to advancing multiple product candidates from our platform…
Karyopharm Therapeutics
- Amanda Bridges
- April 10, 2020
- No Comments
Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of novel first-in-class drugs directed against nuclear export and related targets for the treatment of cancer and other major diseases. Karyopharm’s Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the…
EMD Serono
- Amanda Bridges
- March 22, 2017
- No Comments
EMD Serono is a science-led organization of curious minds dedicated to delivering transformative medicines that can make a difference in the lives of people affected by cancer. We apply our scientific curiosity to tackling challenging tumor types in key areas—gastrointestinal (GI), genitourinary (GU), and thoracic cancers—where there are unmet needs and where we believe we…
Guardant Health
- Amanda Bridges
- March 22, 2017
- No Comments
Guardant Health is a leading precision oncology company dedicated to helping conquer cancer through our proprietary blood tests, vast data sets, and advanced analytics. Click here to listen to Dr. Santos, FLASCO Secretary, discuss the role of liquid biopsy in NSCLC. Dr. Santos shares his experience using Guardant360 in clinical practice, including his perspective…
Kite, a Gilead Company
- Amanda Bridges
- March 8, 2017
- No Comments
Kite, a Gilead Company, is a global biopharmaceutical company based in Santa Monica, California, focused on cell therapy to treat and potentially cure cancer. As the global cell therapy leader, Kite has treated more patients with CAR T-cell therapy than any other company. Kite has the largest in-house cell therapy manufacturing network in the world,…
Novartis
- Amanda Bridges
- July 16, 2015
- No Comments
Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products…
Taiho Oncology
- April 26, 2015
- No Comments
Taiho Oncology, Inc., a division of Taiho Pharmaceutical Co., Ltd. and Otsuka Holdings Co., Ltd., has built a world class clinical development organization that works urgently to develop innovative cancer treatments. Taiho has an oral oncology pipeline consisting of both novel antimetabolic agents and selectively targeted agents. Advanced technology, dedicated researchers, and state of the…
Foundation Medicine
- Amanda Bridges
- February 20, 2015
- No Comments
Foundation Medicine is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient’s unique cancer. The company offers a full suite of comprehensive genomic profiling assays to identify the molecular alterations in a patient’s cancer and…
Lilly Oncology
- November 20, 2014
- No Comments
There’s a time when everything changes. That life-altering moment when someone hears, “You have cancer.” That moment is what motivates everyone at Lilly Oncology. Patient TruAssist Program PatientOne Assistance Program Bridging the Biomarker Gaps Resources Did you know? More than 152,000 Florida residents will face a new cancer diagnosis this year. Each of these…
